Enthesopathies in childhood-onset and adult-onset ankylosing spondylitis
Background. The prevalence of ankylosing spondylitis (AS) among the population reaches 0.3 %, which is much more likely to develop at the age of 20–30 years. Two forms of AS are distinguished: pediatric and adult, depending on the age of the disease debut. The diagnosis of juvenile AS (JAS) is one of the most urgent problems in pediatric rheumatology, while the evolution of this disease in adulthood remains unexplored. JAS is considered as “enthesitis-related arthritis”, which is observed among 10–20 % of the total number of patients. The purpose was to study patients with AS regarding the incidence and nature of the course of enthesopathy and to evaluate its characteristics in childhood- and adult-onset of the disease. Materials and methods. 217 patients with AS (193 men and 24 women) with an average age of 38 years were examined. The fast-progressing course of the disease was detected in 21 % of cases, moderate and high degree of activity — in 79 % of cases, the ІІ–ІІІ stage — in 82 %, and polyarthritis — in 65 %. JAS was detected in 16 % of cases (all boys), among them the third stage occurred twice as often as among the other patients. Results. Enthesopathies are observed in 39 % of the total number of patients with AS, 3.1 times more often in case of JAS, which is characterized by tarsitis, disturbances of the quadriceps tendons, condyles of the femur, sites of insertion to the vertebrae and ribs, and for the disease with an onset in adulthood, the involvement of the Achilles tendons is atypical, moreover, the prognosis-negative signs regarding enthesitis and tendovaginitis are the prevalence of peripheral articular syndrome, the parameters of the integral index of arthritis activity and the Lansbury index, arthritis of the ankle, hip and facet joints, the presence of bone erosion and arthrocalcinates, and in pathogenetic architectonics of enthesopathies the immune disorders are involved, while the distinct manifestation of syndesmophytes and spondyloarthrosis in the vertebrae is common for AS with different age debut of the disease, and in cases of adult-onset disease, in addition, the availability of epiphyseal osteoporosis and bone erosion. Conclusions. JAS is a risk factor for the development of enthesopathies, which have their clinical and pathogenetic features of the course among patients with the different age of the disease debut.
Full Text:PDF (Русский)
Adrovic A, Barut K, Sahin S, Kasapcopur O. Juvenile spondyloarthropathies. Curr Rheumatol Rep 2016; 18 (8): 55-65. doi: 10.1007/s11926-016-0603-y.
Conway R, O'Shea FD. Juvenile versus adult-onset ankylosing spondylitis: are we comparing apples and oranges? J Rheumatol 2012; 39 (5): 887-9. doi: 10.3899/jrheum.120164.
Duarte AP, Marques CD, Bortoluzzo AB, Gonçalves CR, da Silva JA, Ximenes AC, Bértolo MB, Ribeiro SL. Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort. Rev Bras Reumatol 2014; 54 (6): 424-30. doi: 10.1016/j.rbr.2014.06.005.
Haibel H, Sieper J. Enthesitis in connection with spondyloarthritides. Orthopade 2015; 44 (5): 395-406. doi: 10.1007/s00132-015-3114-z.
Jadon DR, Ramanan AV, Sengupta R. Juvenile versus adult-onset ankylosing spondylitis – clinical, radiographic, and social outcomes. a systematic review. J Rheumatol 2013; 40 (11): 1797-805. doi: 10.3899/jrheum.130542.
Katsicas MM, Russo R. Biologic agents in juvenile spondyloarthropathies. Pediatr Rheumatol Online J 2016; 14 (1): 17-27. doi: 10.1186/s12969-016-0076-6.
Malaviya AN, Sawhney S, Mehra NK, Kanga U. Seronegative arthritis in South Asia: an up-to-date review. Curr Rheumatol Rep 2014; 16 (4): 413-23. doi: 10.1007/s11926-014-0413-z.
Mease PJ, Van den Bosch F, Sieper J, Xia Y, Pangan AL, Song IH. Performance of 3 enthesitis indices in patients with peripheral spondyloarthritis during treatment with adalimumab. J Rheumatol 2017; 15 (3): 230-6. doi: 10.3899/jrheum.160387.
Mou Y, Zhang P, Li Q, Lin Z, Liao Z, Wei Q, Gu J. Clinical features in juvenile-onset ankylosing spondylitis patients carrying different B27 subtypes. Biomed Res Int 2015; 20 (15): 594878. doi: 10.1155/2015/594878.
Roberts AR, Appleton LH, Cortes A, Vecellio M, Lau J, Watts L, Brown MA, Wordsworth P. ERAP1 association with ankylosing spondylitis is attributable to common genotypes rather than rare haplotype combinations. Proc Natl Acad Sci U S A 2017; 114 (3): 558-61. doi: 10.1073/pnas.1618856114.
Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K. 2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in Canada. J Rheumatol 2015; 42 (4): 654-64. doi: 10.3899/jrheum.141000.
Shahlaee A, Mahmoudi M, Nicknam MH, Farhadi E, Fallahi S, Jamshidi AR. Gender differences in Iranian patients with ankylosing spondylitis. Clin Rheumatol 2015; 34 (2): 285-93. doi: 10.1007/s10067-013-2439-4.
Srivastava R, Agnihotry S, Aggarwal R, Bajpai P, Aggarwal A. HLA-B27 subtypes in enthesitis-related arthritis category of juvenile idiopathic arthritis and ankylosing spondylitis in northern India. Clin Exp Rheumatol 2015; 33 (6): 931-5.
Srivastava R, Phatak S, Aggarwal A. ERAP1 rs30187 single nucleotide polymorphism does not confer disease susceptibility in North Indian children with enthesitis-related arthritis. Clin Rheumatol 2017; 4 (2): 155-9. doi: 10.1007/s10067-017-3560-6.
Tse SM, Laxer RM. New advances in juvenile spondyloarthritis. Nat Rev Rheumatol 2012; 8 (5): 269-79. doi: 10.1038/nrrheum.2012.37.
Usenbo A, Kramer V, Young T, Musekiwa A. Prevalence of arthritis in Africa: A systematic review and meta-analysis. PLoS One 2015; 10 (8): 0133858. doi: 10.1371/journal.pone.0133858.
Weiss PF. Diagnosis and treatment of enthesitis-related arthritis. Adolesc Health Med Ther 2012; 12 (3): 67-74.
Xia Q, Fan D, Yang X, Li X, Zhang X, Wang M, Xu S, Pan F. Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis: A systematic review and meta-analysis. Medicine 2017; 96 (4): 5960. doi: 10.1097/MD.0000000000005960.
Xiang Q, Chen L, Fang J, Hou S, Wei L, Bai L, Liu Y, Zhou Y, Kijlstra A, Yang P. TNF receptor-associated factor 5 gene confers genetic predisposition to acute anterior uveitis and pediatric uveitis. Arthritis Res Ther. 2013; 15 (5): 113-4.
- There are currently no refbacks.
Copyright (c) 2017 TRAUMA
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2017